Soleil Securities initiates coverage on Bio-Rad Laboratories (NYSE: BIO) with a Buy. Price target $91.

Soliel analyst says, "Over 70 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE